RetinalGenix Technologies (RTGN) Free Cash Flow Growth (3y) (2023 - 2026)
Analysis
RetinalGenix Technologies (RTGN) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.78 Bn | 27.67 Bn | 2.18 Bn | 35.65% |
| 2 | Lantheus Holdings | 6.58 Bn | 5.99 Bn | 241.86 Mn | 60.39% |
| 3 | Heartflow | 4.12 Bn | 3.74 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.60 Bn | 2.41 Bn | 107.80 Mn | -26.31% |
| 5 | Butterfly Network | 1.99 Bn | 1.86 Bn | 23.29 Mn | 14.27% |
| 6 | Ceribell | 922.09 Mn | 792.82 Mn | 25.94 Mn | - |
| 7 | QuidelOrtho | 883.12 Mn | 759.72 Mn | - | -18.45% |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | -28.98% |
| 9 | Prenetics Global | 341.11 Mn | 282.06 Mn | 30.20 Mn | -19.30% |
| 10 | RetinalGenix Technologies | 75.37 Mn | 75.35 Mn | - | -3.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.35% |
| Mar 31, 2026 | -12.08% |
| Dec 31, 2025 | -56.85% |
| Sep 30, 2025 | -20.77% |
| Jun 30, 2025 | -138.01% |
| Mar 31, 2025 | -24.60% |
| Dec 31, 2024 | 13.76% |
| Sep 30, 2024 | -5.10% |
| Jun 30, 2024 | 18.20% |
| Mar 31, 2024 | 26.43% |
| Dec 31, 2023 | 7.94% |